For many patients with glioblastoma, theres a thought that if the standard of care is combined with other types of therapies/treatments, better outcomes may exist. In the case of Ben Trotman, a dad of one and loving husband who received his glioblastoma diagnosis nearly three years ago at age 40, taking the drug ipilimumab a type of immunotherapy prior to standard glioblastoma treatment may have assisted in him becoming cancer-free.